BIOMARIN PHARMACEUTICAL INC Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Biomarin Pharmaceutical Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$38.8M, a 9.38% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$526M, a 2711% decline from 2023.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$18.7M, a 0.41% decline from 2022.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$18.7M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$38.8M +$4.01M +9.38% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q1 2024 -$42.8M -$2.05M -5.03% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q1 2023 -$40.7M -$15.5M -61.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q1 2022 -$25.3M -$916K -3.76% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q1 2021 -$24.4M -$4.69M -23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q1 2020 -$19.7M +$5.31M +21.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q1 2019 -$25M -$15.2M -156% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 -$9.77M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2014 $137M +$123M +891% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-02
Q1 2013 $13.8M +$375K +2.79% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q1 2012 $13.4M +$10.2M +316% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q1 2011 $3.23M -$5.91M -64.6% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q1 2010 $9.14M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29

BIOMARIN PHARMACEUTICAL INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$526M -$508M -2711% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-24
2023 -$18.7M -$77K -0.41% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-24
2022 -$18.7M -$18.6M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-24
2021 -$48K* -$181M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $181M +$256M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$74.7M +$313M +80.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$388M -$895M -177% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $507M -$220M -30.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $727M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2013 $747M +$434M +139% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-26
2012 $312M +$283M +964% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-26
2011 $29.3M +$25.8M +737% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $3.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.